CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.31B | 1.29B | 1.28B | 1.26B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32B | 1.31B | 1.29B | 1.28B | 1.26B |
| Cost of Revenue | 573.78M | 572.38M | 567.55M | 564.17M | 560.56M |
| Gross Profit | 742.22M | 734.63M | 720.56M | 711.83M | 700.99M |
| SG&A Expenses | 534.22M | 519.23M | 515.89M | 511.26M | 510.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16B | 1.15B | 1.14B | 1.13B | 1.12B |
| Operating Income | 154.22M | 160.98M | 149.39M | 146.39M | 137.00M |
| Income Before Tax | 145.28M | 163.03M | 160.07M | 123.90M | 103.80M |
| Income Tax Expenses | 26.53M | 30.61M | 28.33M | 25.30M | 21.46M |
| Earnings from Continuing Operations | 118.75 | 132.42 | 131.74 | 98.59 | 82.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 118.75M | 132.42M | 131.74M | 98.59M | 82.35M |
| EBIT | 154.22M | 160.98M | 149.39M | 146.39M | 137.00M |
| EBITDA | 224.90M | 231.44M | 219.55M | 216.44M | 207.28M |
| EPS Basic | 3.85 | 4.29 | 4.28 | 3.20 | 2.68 |
| Normalized Basic EPS | 2.39 | 2.51 | 2.26 | 2.19 | 1.99 |
| EPS Diluted | 3.80 | 4.24 | 4.21 | 3.14 | 2.61 |
| Normalized Diluted EPS | 2.37 | 2.48 | 2.23 | 2.14 | 1.94 |
| Average Basic Shares Outstanding | 123.57M | 123.37M | 123.21M | 123.09M | 122.94M |
| Average Diluted Shares Outstanding | 124.52M | 124.64M | 124.99M | 125.57M | 126.26M |
| Dividend Per Share | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| Payout Ratio | 20.78% | 18.62% | 18.69% | 24.96% | 29.82% |